Wow - this is looking horrible, a ~10m negative swing straight into the opening quarter. How could it go so far in the red. Slow growth, 31% drop in sales and no profitability in sight. Burning through cash, they will have to do another CR!
Given they are building a much higher capacity Colorado facility, they will need a degree of private label sales they've ditched to fill the capacity and ensure US competitors don't out produce them - Private label does have its place in a companies portfolio as retailers are usually more willing entertain ranging their brands if a manufacturer plays ball on some private label products. Also, using a broker who controls retail relationships and takes a cut - what does this look like long term?
Some facts, they burnt through $15m in cash in 1st quarter with not much to show (acquisitions, sales growth etc.):
Also expected outflows next quarter ~25m, surely that gives them 4-6 months runway before CR given no profitability:
- Forums
- ASX - By Stock
- Ann: Quarterly Report and Appendix 4C
EXL
elixinol wellness limited
Add to My Watchlist
6.67%
!
1.4¢

Wow - this is looking horrible, a ~10m negative swing straight...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.4¢ |
Change
-0.001(6.67%) |
Mkt cap ! $3.222M |
Open | High | Low | Value | Volume |
1.4¢ | 1.4¢ | 1.4¢ | $27 | 1.927K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 199 | 1.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.6¢ | 1250 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 199 | 0.014 |
4 | 279909 | 0.013 |
3 | 358267 | 0.012 |
8 | 1105357 | 0.011 |
7 | 565391 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.016 | 1250 | 1 |
0.017 | 237147 | 2 |
0.018 | 4690 | 1 |
0.019 | 8750 | 1 |
0.020 | 55500 | 2 |
Last trade - 10.56am 04/07/2025 (20 minute delay) ? |
Featured News
EXL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online